Navigation Links
AACR, NCI and EORTC to host Molecular Targets and Cancer Therapeutics International Conference
Date:11/9/2009

PHILADELPHIA Scientists and industry leaders from around the world will gather in Boston Nov. 14-19, 2009, for the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference, which will feature groundbreaking information on important cancer therapies in development.

"Cancer is a complex disease and to treat it effectively we need a greater understanding of the activity that takes place at the molecular level," said Lewis Cantley, Ph.D., director of the cancer center at Beth Israel Deaconess Medical Center and one of the scientific committee chairpersons of the conference. "The research presented at this conference will bring us closer to that understanding."

Experts from the world's leading cancer centers and pharmaceutical companies will discuss innovations in drug development, target selection and the impact of new discoveries in molecular and cellular biology.

Understanding the pathways and mechanisms that cause cancer and regulate the biological behavior of tumor cells has already led to the development of numerous new agents. This conference, now in its second decade, has been organized to reflect the many recent advances in the early development of promising new compounds.

During the conference, the American Association for Cancer Research will host several press briefings: "Drugs in the Pipeline," "Emerging Therapies in Pancreatic Cancer" and "Markers of Prognosis."


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related biology news :

1. AACR, NCI and EORTC to host molecular targets and cancer therapeutics conference
2. AACR, BCRF award inaugural grants in translational breast cancer research
3. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
4. Trembling hands and molecular handshakes
5. NHLBI awards $11 million for molecular roadmap to chronic lung diseases
6. Cements basic molecular structure finally decoded
7. Powerful new molecular GPS helps probe aging and disease processes
8. Think zinc: Molecular sensor could reveal zincs role in diseases
9. Stimulus funding helps K-State bring undergrads to prairie for ecology, molecular biology research
10. Pitt study finds molecular link between insulin resistance and inflammation
11. Stem cell research: From molecular physiology to therapeutic applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... line of medical marijuana products targeting the needs of consumers who are incorporating ... Kindred takes place in Phoenix, Arizona. , As operators of two successful Valley ...
(Date:10/7/2017)... ... October 06, 2017 , ... Phase ... metagenome deconvolution product, featuring the first commercially available Hi-C kit. Researchers can ... Hi-C metagenome deconvolution using their own facilities, supplementing the company’s full-service ProxiMeta ...
(Date:10/6/2017)... ... October 06, 2017 , ... ... lunch discussion and webinar on INSIGhT, the first-ever adaptive clinical trial for glioblastoma ... Cancer Institute. The event is free and open to the public, but registration ...
Breaking Biology Technology: